Anew Medical Inc. (WENA)
NASDAQ: WENA
· Real-Time Price · USD
0.73
-0.03 (-3.31%)
At close: Sep 16, 2024, 10:00 PM
Company Description
Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics.
Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.
The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases.
Anew Medical, Inc. is based in Omaha, Nebraska.
Anew Medical Inc.
| Country | United States |
| IPO Date | n/a |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Joseph Sinkule |
Contact Details
Address: 13576 Walnut Street Omaha, Nebraska United States | |
| Website | https://www.anewmeds.com |
Stock Details
| Ticker Symbol | WENA |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | 03465T108 |
| ISIN Number | US03465T1088 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. Joseph Sinkule Pharm.D. | Founder, Chief Executive Officer, Chairman of the Board & Secretary |
| Jeffrey LeBlanc | Chief Financial Officer |
| Peter J. Moriarty | Chief Operating Officer |
| Dr. Miguel Chillon Rodriguez | Chief Scientific Officer & Consultant |
| Dr. Shalom Z. Hirschman M.D. | Chief Medical Officer of Emeritus & Independent Director |